Pancreatic Cancer Research

ResearcherNova Scotia Health AuthorityActive in the last 2 years

Carley Bekkers

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-5344-3501; OpenAlex author ID A5060517616. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers

Papers 3

  1. Claudin 18 (43-14A clone) expression in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for zolbetuximab therapy. Co-author DOI 10.1016/j.tranon.2025.102362↗
  2. Peri-tumoural lymphocyte neighbourhoods predict longer survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2025.1730817↗
  3. Glypican-3 and Cytokeratin-19 Expression in Pancreatic Cancer in a Canadian Population. Co-author DOI 10.3390/jcm13226893↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Thomas Arnason · 3 shared papers, 2024–2025 · strength 0.87
  2. Ravi Ramjeesingh · 3 shared papers, 2024–2025 · strength 0.87
  3. Boris Gala-López · 2 shared papers, 2025 · strength 0.51
  4. Riley J. Arseneau · 2 shared papers, 2025 · strength 0.51
  5. Thomas Samson · 2 shared papers, 2025 · strength 0.51
  6. Stacey N. Lee · 1 shared paper, 2025 · strength 0.24
  7. Jeanette E. Boudreau · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.